Submitted by baileylynn_100964 on Mon, 02/08/2021 - 21:44

McLaughlin leads research on identifying minimally invasive biomarkers for MS

Penn State News
10 April 2018

A study at Penn State College of Medicine may show a new way to monitor the progression and treatment of multiple sclerosis (MS). It showed new, less invasive biomarkers ­— statistical indicators used to measure the presence and severity of a disease. Experimental Biology and Medicine published an article about the study in its Jan. 7 issue (see​​​​​​​).

Type of Video